Whalesbook
The Indian government is nearing the finalization of a Minimum Import Price (MIP) for several crucial pharmaceutical raw materials, including active pharmaceutical ingredients (APIs). This measure aims to protect the domestic industry from predatory pricing by Chinese suppliers and promote self-reliance ('Atmanirbhar Bharat'). The policy, currently with the health ministry, is expected to cover vital inputs like Penicillin-G, 6APA, and Amoxicillin, in addition to existing controls on ATS-8 and sulphadiazine.